Zhao Q, Yang R, Wang J, Hu D-D, Li F
Regulatory Approvals & Global Adoption GLP-1 receptor agonists have received approvals from several regulatory authorities
A 2026 UK review of the May 2026 UCSF Annals of Neurology study showing "normal" but lower active B12 is linked to slower thinking and more white-matter brain injury, NICE NG239, the homocysteineDNA-methylation mechanism that suppresses hippocampal neurotrophins, the VITACOG brain-atrophy trial, pernicious anaemia, metformin and PPI depletion and why replacing the B12 comes first, not a peptide Read the full review Metabolic Neuropsychiatry & Cognitive Health 20 May 2026 Dihexa & GLP-1 Drugs (Ozempic, Wegovy, Mounjaro) and the Brain: The 2026 UK Review Do GLP-1 drugs like Ozempic, Wegovy and Mounjaro protect the brain or cause brain fog
For IV infusion, IM and SC Glutathione 1200mg * 10 vials Powerful antioxidant Improves liver function and reduces inflammation The Glutanex Injection by Nexus Pharma is approved for On-Label Usage as per the MFDS/KFDA Standard, specifically for the prevention of nervous system symptoms due to chemical treatments